Aptamers are single-stranded DNA or RNA that bind to their targets with high specificity and affinity . Recently, they became an excellent alternatives for antibodies in numerous applications.

In your opinion, can aptamers fully replace monoclonal antibodies in near future?

Is it of high importamce to build a global and updated database for the developed aptamers?

In which applications do you expect aptamer will incorporate in ?

Similar questions and discussions